WED 8/19: URGN – BUYING (1/3) @ $50.40

James F. Taulman
James F. Taulman
James had served as Editor-in-Chief of the first independently licensed website to offer stock reports and services based on the CAN SLIM® investment system. •

3:44 PM – Initiating a 1/3 position in this Biotech stock near the close as shares display several bullish technical characteristics: (1) trading higher from near the 10 DMA, (2) breaking out above the ROUND-$50 level, and (3) trading on a massive 200% increase in volume. I cannot ignore this combination of bullish price-and-volume action, so I’m taking an initial position here.

James’ Trader’s Tip: When the Evidence Stacks Up, Pay Attention

  • Advancing from the 10 DMA provides an initial sign of technical strength.

  • Breaking through a key resistance level adds further confirmation.

  • When those signals are accompanied by a massive increase in volume, the stock is clearly demanding attention.

https://buyingbreakouts.com/wed-8-19-urgn-buying-1-3-50-40/

Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.

Comments

Back to TalkMarkets